Jose E Tanus-Santos Selected Research

Genetic Markers (Genetic Marker)

5/2015	Effects of NAMPT polymorphisms and haplotypes on circulating visfatin/NAMPT levels in hypertensive disorders of pregnancy.
1/2011	Endothelial nitric oxide genotypes and haplotypes are not associated with end-stage renal disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jose E Tanus-Santos Research Topics

Disease

65	Hypertension (High Blood Pressure) 12/2023 - 02/2002
28	Pulmonary Embolism 10/2021 - 01/2002
26	Pre-Eclampsia (Preeclampsia) 01/2021 - 07/2008
25	Cardiovascular Diseases (Cardiovascular Disease) 01/2023 - 07/2002
16	Pulmonary Hypertension 10/2021 - 01/2002
14	Renovascular Hypertension (Goldblatt Syndrome) 02/2018 - 10/2002
13	Vascular Remodeling 02/2024 - 06/2008
11	Thrombosis (Thrombus) 10/2021 - 07/2002
9	Hypotension (Low Blood Pressure) 12/2022 - 09/2005
9	Cardiomegaly (Heart Hypertrophy) 03/2020 - 04/2010
9	Hypertrophy 12/2015 - 09/2008
8	Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced) 08/2016 - 07/2008
6	Migraine Disorders (Migraine) 01/2013 - 07/2010
5	Erectile Dysfunction 12/2015 - 09/2004
5	Fibrosis (Cirrhosis) 10/2015 - 10/2002
4	Hemolysis 01/2014 - 12/2002
4	Chronic Kidney Failure (Chronic Renal Failure) 12/2012 - 01/2011
3	Pediatric Obesity 01/2015 - 07/2009
3	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 08/2014 - 12/2010
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2013 - 12/2008
3	Epilepsy (Aura) 01/2013 - 06/2011
3	Type 2 Diabetes Mellitus (MODY) 05/2007 - 11/2006
2	Necrosis 01/2019 - 10/2002
2	Obesity 05/2015 - 09/2011
2	Periodontal Diseases (Periodontal Disease) 06/2013 - 11/2009
2	Inflammation (Inflammations) 03/2013 - 08/2007

Drug/Important Bio-Agent (IBA)

65	Matrix Metalloproteinases (MMPs)IBA 01/2022 - 09/2005
41	Nitric Oxide (Nitrogen Monoxide)FDA Link 02/2024 - 01/2002
28	NitritesIBA 02/2024 - 12/2006
24	Antihypertensive Agents (Antihypertensives)IBA 01/2023 - 12/2006
23	AntioxidantsIBA 10/2021 - 01/2006
14	Sildenafil Citrate (Viagra)FDA Link 12/2015 - 09/2004
14	Matrix Metalloproteinase 9 (Gelatinase B)IBA 11/2012 - 09/2005
12	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2018 - 11/2006
12	Doxycycline (Periostat)FDA LinkGeneric 01/2014 - 09/2005
9	Matrix Metalloproteinase 2 (Gelatinase A)IBA 02/2024 - 11/2005
9	Sodium NitriteIBA 01/2023 - 07/2011
9	Nitric Oxide Synthase (NO Synthase)IBA 02/2022 - 07/2002
9	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2022 - 05/2009
9	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 02/2009
9	Matrix Metalloproteinase InhibitorsIBA 01/2014 - 06/2010
8	NitratesIBA 12/2023 - 12/2013
8	APTIBA 10/2021 - 12/2006
7	tempolIBA 10/2021 - 05/2009
7	salicylhydroxamic acid (SHAM)IBA 03/2020 - 06/2008
7	Tissue Inhibitor of Metalloproteinase-2IBA 01/2015 - 07/2008
6	CollagenIBA 10/2015 - 05/2012
6	Hemoglobins (Hemoglobin)IBA 01/2014 - 12/2002
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2011
5	Biomarkers (Surrogate Marker)IBA 10/2019 - 02/2006
5	NG-Nitroarginine Methyl Ester (L-NAME)IBA 01/2018 - 10/2002
5	Atorvastatin (Lipitor)FDA Link 12/2015 - 09/2004
5	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 02/2014 - 12/2010
4	AdipokinesIBA 10/2023 - 02/2014
4	Propofol (Diprivan)FDA LinkGeneric 12/2022 - 01/2018
4	Vasodilator Agents (Vasodilators)IBA 10/2021 - 01/2002
4	Arginine (L-Arginine)FDA Link 09/2021 - 11/2005
4	Xanthine DehydrogenaseIBA 01/2021 - 06/2014
4	Acetylcholine (Acetylcholine Chloride)FDA Link 01/2021 - 10/2016
4	Eosine Yellowish-(YS) (Eosin)IBA 10/2015 - 02/2013
4	NADPH Oxidases (NAD(P)H oxidase)IBA 08/2015 - 07/2011
4	Troponin IIBA 03/2013 - 02/2008
4	Metalloproteases (Metalloproteinases)IBA 12/2012 - 06/2008
4	Tissue Inhibitor of MetalloproteinasesIBA 04/2012 - 02/2006
4	Tissue Inhibitor of Metalloproteinase-1IBA 08/2011 - 07/2006
4	lercanidipineIBA 01/2011 - 01/2006
3	S-NitrosothiolsIBA 01/2023 - 10/2015
3	EnzymesIBA 01/2022 - 01/2011
3	Transforming Growth Factors (Transforming Growth Factor)IBA 03/2020 - 02/2013
3	AnionsIBA 01/2019 - 12/2006
3	Losartan (Cozaar)FDA LinkGeneric 02/2018 - 02/2012
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2017 - 09/2004
3	AdiponectinIBA 08/2016 - 08/2013
3	Thiobarbituric Acid Reactive SubstancesIBA 08/2016 - 10/2008
3	C.I. direct red 80IBA 10/2015 - 02/2013
3	Hematoxylin (Haematoxylon)IBA 08/2014 - 02/2013
3	Superoxides (Superoxide)IBA 06/2014 - 12/2013
3	CytokinesIBA 02/2014 - 07/2010
3	Peroxidase (Myeloperoxidase)IBA 06/2013 - 02/2010
2	Cell-Free Nucleic AcidsIBA 01/2021 - 11/2009
2	Nicotinamide PhosphoribosyltransferaseIBA 01/2021 - 05/2015
2	Omeprazole (Prilosec)FDA LinkGeneric 01/2021 - 10/2016
2	Tyrosine (L-Tyrosine)FDA Link 10/2019 - 08/2008
2	Messenger RNA (mRNA)IBA 01/2019 - 09/2008
2	aliskiren FDA Link 02/2018 - 08/2013
2	Renin InhibitorsIBA 02/2018 - 08/2013
2	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 05/2017 - 01/2011
2	Enalapril FDA LinkGeneric 01/2016 - 12/2012
2	Genetic Markers (Genetic Marker)IBA 05/2015 - 01/2011
2	Drinking WaterIBA 08/2014 - 05/2012
2	Nebivolol FDA Link 08/2014 - 12/2013
2	Metoprolol (Toprol-XL)FDA LinkGeneric 08/2014 - 12/2013
2	3-nitrotyrosineIBA 08/2014 - 12/2013
2	ElastinIBA 08/2013 - 05/2012
2	Tissue Plasminogen Activator (Alteplase)FDA Link 07/2013 - 06/2010

Therapy/Procedure

22	Therapeutics 01/2023 - 01/2002
20	Surgical Instruments (Clip) 09/2021 - 10/2002
4	Microspheres (Microsphere) 07/2013 - 09/2005
3	Anesthesia 12/2022 - 01/2018
2	Thrombolytic Therapy 07/2013 - 06/2010